Rome Considering Limiting Tourist Access to Trevi Fountain

FILE PHOTO: Crowds of tourists visit the Trevi Fountain in Rome, Italy, August 8, 2024. REUTERS/Guglielmo Mangiapane/File Photo
FILE PHOTO: Crowds of tourists visit the Trevi Fountain in Rome, Italy, August 8, 2024. REUTERS/Guglielmo Mangiapane/File Photo
TT

Rome Considering Limiting Tourist Access to Trevi Fountain

FILE PHOTO: Crowds of tourists visit the Trevi Fountain in Rome, Italy, August 8, 2024. REUTERS/Guglielmo Mangiapane/File Photo
FILE PHOTO: Crowds of tourists visit the Trevi Fountain in Rome, Italy, August 8, 2024. REUTERS/Guglielmo Mangiapane/File Photo

Rome is considering limiting access to the Trevi Fountain, one of its busiest monuments, ahead of an expected bumper year for tourism in the Eternal City, city council officials say.
The Italian capital is preparing to host the 2025 Jubilee, a year-long Roman Catholic event expected to attract 32 million tourists and pilgrims.
Under the draft plans, visits to the fountain would require a prior reservation, with fixed time slots and a limited number of people allowed to access the steps around it, Reuters reported.
"For Romans we are thinking of making it free, while non-residents would be asked to make a symbolic contribution, one or two euros ($1.1-2.2)", Rome's tourism councillor Alessandro Onorato told Thursday's Il Messaggero newspaper.
On Wednesday, Mayor Roberto Gualtieri called measures to curb tourist numbers "a very concrete possibility."
"The situation at the Trevi Fountain is becoming technically very difficult to manage," he told reporters.
Other cities are facing protests over problems brought by so-called overtourism, including Barcelona and Venice, where local authorities tested this year an entry charge scheme for visitors.
The Trevi Fountain, where tradition dictates that visitors toss a coin to guarantee their return to Rome and fulfil their wishes, has long been a major attraction, even for visiting world leaders.
Completed in 1762, the monument is a late Baroque masterpiece, with statues of Tritons guiding the shell chariot of the god Oceanus, illustrating the theme of the taming of the waters.
It is also remembered for one of cinema's most famous scenes when in Federico Fellini's "La Dolce Vita" Anita Ekberg wades into the fountain and beckons her co-star Marcello Mastroianni to join her: "Marcello! Come here!"



Rwanda and WHO Declare End of Marburg Outbreak after No New Cases Reported

In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)
In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)
TT

Rwanda and WHO Declare End of Marburg Outbreak after No New Cases Reported

In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)
In this Oct. 8, 2014 photo, a medical worker from the Infection Prevention and Control unit wearing full protective equipment carries a meal to an isolation tent housing a man being quarantined after coming into contact in Uganda with a carrier of the Marburg Virus, at the Kenyatta National Hospital in Nairobi, Kenya. (AP)

The World Health Organization and the Rwandan government on Friday declared the outbreak in Rwanda of the Ebola-like Marburg fever over after no new cases were registered in recent weeks.

The country first declared the outbreak on Sept. 27 and reported a total of 15 deaths and 66 cases, with the majority of those affected healthcare workers who handled the first patients.

Without treatment, Marburg can be fatal in up to 88% of people who fall ill with the disease. Symptoms include fever, muscle pains, diarrhea, vomiting and, in some cases, death through extreme blood loss.

There is no authorized vaccine or treatment for Marburg, though Rwanda received hundreds of doses of a vaccine under trial in October.

An outbreak is considered over after 42 days — two 21-day incubation cycles of the virus — elapsed without registering new cases and all existing cases test negative.

Rwanda discharged the last Marburg patient on Nov. 8 and had reported no new confirmed cases since Oct. 30.

However, WHO officials and Rwanda's Health Minister Dr. Sabin Nzanzimana on Friday said risks remain and that people should stay vigilant.

“We believe it’s not completely over because we still face risks, especially from bats. We are continuing to build new strategies, form new health teams, and deploy advanced technologies to track their movements, understand their behavior, and monitor who is interacting with them,” the minister announced during a press conference in the capital, Kigali.

Like Ebola, the Marburg virus is believed to originate in fruit bats and spreads between people through close contact with the bodily fluids of infected individuals or with surfaces, such as contaminated bed sheets.

“I thank the government of Rwanda, its leadership and Rwandans in general for the strong response to achieve this success but the battle continues,” said the WHO representative in Rwanda, Dr. Brain Chirombo.

Marburg outbreaks and individual cases have in the past been recorded in Tanzania, Equatorial Guinea, Angola, Congo, Kenya, South Africa, Uganda and Ghana.

The virus was first identified in 1967 after it caused simultaneous outbreaks of disease in laboratories in the German city of Marburg and in Belgrade in the former Yugoslavia. Seven people died after being exposed to the virus while conducting research on monkeys.